X
X T L Biopharmaceuticals Ltd
TASE:XTLB
X T L Biopharmaceuticals Ltd
TASE:XTLB
Price:
2.1
ILS
-4.55%
Market Closed
Market Cap:
₪19.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X
|
X T L Biopharmaceuticals Ltd
TASE:XTLB
|
IL |
|
M
|
Macmic Science & Technology Co Ltd
SSE:688711
|
CN |
|
XiAn Catering Co Ltd
SZSE:000721
|
CN |
|
C
|
Covivio Hotels SCA
LSE:0IS8
|
FR |
|
H
|
Humble Group AB
STO:HUMBLE
|
SE |
|
IVF Hartmann Holding AG
LSE:0QQM
|
CH |
|
XP Power Ltd
LSE:XPP
|
SG |
|
Bilici Yatirim Sanayi ve Ticaret AS
IST:BLCYT.E
|
TR |
|
LENSAR Inc
NASDAQ:LNSR
|
US |
|
Jones Lang LaSalle Inc
NYSE:JLL
|
US |
|
Fine-Line Circuits Ltd
BSE:517264
|
IN |
|
I
|
Innovative Industrial Properties Inc
NYSE:IIPR
|
US |
|
DatChat Inc
NASDAQ:DATS
|
US |
|
Federal Realty Investment Trust
NYSE:FRT
|
US |
|
Shun Tak Holdings Ltd
HKEX:242
|
HK |
|
S
|
Silla Co Ltd
KRX:004970
|
KR |
|
Matsuya Foods Holdings Co Ltd
TSE:9887
|
JP |
|
Ugro Capital Ltd
NSE:UGROCAP
|
IN |
|
Z
|
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
|
CN |
|
S
|
Shaanxi Meibang Pharmaceutical Group Co Ltd
SSE:605033
|
CN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of XTLB.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XTLB
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
XTLB Competitors Multiples
X T L Biopharmaceuticals Ltd Competitors
X T L Biopharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
X
|
X T L Biopharmaceuticals Ltd
TASE:XTLB
|
19.9m ILS | 0 | 2.1 | -2 | -2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.6 | 12.3 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.2 | 27.8 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.2 | 35.1 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
